Table 1.
Comparisons of clinical and demographic features among the MS and OND subgroups.
Figure 1.
Dendrogram that resulted from the clusters analysis within the MS population.
See Table 2 for details.
Table 2.
Clinical differences between clusters, and list of defined peptides that resulted differentially expressed between the subgroups.
Figure 2.
Distribution of selected peak signals intensities in the different MS groups and in dementia and CIDP patients.
Values on Y-axes are expressed as log10 of peak signals intensity; *Fibrinogen signal is not detectable in patients with dementia.
Table 3.
Fold-changes of the peak signals intensity between the subgroups.
Figure 3.
Scattered plots representing the correlations of (A) Secretogranin II, (B) Fibrinogen, (C) Fibrinopeptide-A, and the EDSS scores in the MS population.